chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 17.0
Sex: F
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: 17 year old; This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (17 year old) in a 17-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Mar-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (17 year old). On 17-Mar-2021, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (17 year old) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Products known to have been used by the patient, within two weeks prior to the event were not provided.  No laboratory investigations were provided. The Treatment information and concomitant medication was not provided.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Fall, Headache, Pain
Clinical narrative: She fell down in the afternoon on same day; she got hurt; Patient started with headache on same day after receiving 1st dose; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of FALL (She fell down in the afternoon on same day), PAIN (she got hurt) and HEADACHE (Patient started with headache on same day after receiving 1st dose) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036B21A) for COVID-19 vaccination.     Concomitant products included LISINOPRIL, ESCITALOPRAM, AMLODIPINE and HCTZ for an unknown indication.   On 12-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On 12-Apr-2021, the patient experienced FALL (She fell down in the afternoon on same day), PAIN (she got hurt) and HEADACHE (Patient started with headache on same day after receiving 1st dose). The patient was treated with NAPROXEN at an unspecified dose and frequency and CYCLOBENZAPRINE at an unspecified dose and frequency. At the time of the report, FALL (She fell down in the afternoon on same day), PAIN (she got hurt) and HEADACHE (Patient started with headache on same day after receiving 1st dose) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       This case was linked to US-MODERNATX, INC.-MOD-2021-080001 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-080001:Cross-Linked case
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Decreased appetite, Dizziness, Fatigue
Clinical narrative: migraine headache; Appetite lost; Dizziness; itching; Numb face; tingling; Joint ache; Muscle ache; Vomiting; Fatigue; chills; fever; pain in arm; This spontaneous case was reported by a consumer and describes the occurrence of MIGRAINE (migraine headache), DECREASED APPETITE (Appetite lost), DIZZINESS (Dizziness), PRURITUS (itching) and HYPOAESTHESIA (Numb face) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 025B21A and 006B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Penicillin allergy, Drug allergy (sulfa, gluten, azithromycin,), Food allergy (corn) and Hypothyroidism.   On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 2 dosage form. On 18-Mar-2021, the patient experienced VACCINATION SITE PAIN (pain in arm). On 15-Apr-2021, the patient experienced MIGRAINE (migraine headache), DECREASED APPETITE (Appetite lost), DIZZINESS (Dizziness), PRURITUS (itching), HYPOAESTHESIA (Numb face), PARAESTHESIA (tingling), ARTHRALGIA (Joint ache), MYALGIA (Muscle ache), VOMITING (Vomiting), FATIGUE (Fatigue), CHILLS (chills) and PYREXIA (fever). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) at an unspecified dose and frequency. At the time of the report, MIGRAINE (migraine headache), DECREASED APPETITE (Appetite lost), DIZZINESS (Dizziness), VACCINATION SITE PAIN (pain in arm), ARTHRALGIA (Joint ache), MYALGIA (Muscle ache), FATIGUE (Fatigue), CHILLS (chills) and PYREXIA (fever) had not resolved and PRURITUS (itching), HYPOAESTHESIA (Numb face), PARAESTHESIA (tingling) and VOMITING (Vomiting) had resolved.            Other concomitant medications include hypothyroidism medication.   This case was linked to US-MODERNATX, INC.-MOD-2021-080118, US-MODERNATX, INC.-MOD-2021-080159 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-080118:Husband's case crosslinked US-MODERNATX, INC.-MOD-2021-080159:
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia, Migraine, Myalgia, Paraesthesia, Pruritus
Clinical narrative: migraine headache; Appetite lost; Dizziness; itching; Numb face; tingling; Joint ache; Muscle ache; Vomiting; Fatigue; chills; fever; pain in arm; This spontaneous case was reported by a consumer and describes the occurrence of MIGRAINE (migraine headache), DECREASED APPETITE (Appetite lost), DIZZINESS (Dizziness), PRURITUS (itching) and HYPOAESTHESIA (Numb face) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 025B21A and 006B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Penicillin allergy, Drug allergy (sulfa, gluten, azithromycin,), Food allergy (corn) and Hypothyroidism.   On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 2 dosage form. On 18-Mar-2021, the patient experienced VACCINATION SITE PAIN (pain in arm). On 15-Apr-2021, the patient experienced MIGRAINE (migraine headache), DECREASED APPETITE (Appetite lost), DIZZINESS (Dizziness), PRURITUS (itching), HYPOAESTHESIA (Numb face), PARAESTHESIA (tingling), ARTHRALGIA (Joint ache), MYALGIA (Muscle ache), VOMITING (Vomiting), FATIGUE (Fatigue), CHILLS (chills) and PYREXIA (fever). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) at an unspecified dose and frequency. At the time of the report, MIGRAINE (migraine headache), DECREASED APPETITE (Appetite lost), DIZZINESS (Dizziness), VACCINATION SITE PAIN (pain in arm), ARTHRALGIA (Joint ache), MYALGIA (Muscle ache), FATIGUE (Fatigue), CHILLS (chills) and PYREXIA (fever) had not resolved and PRURITUS (itching), HYPOAESTHESIA (Numb face), PARAESTHESIA (tingling) and VOMITING (Vomiting) had resolved.            Other concomitant medications include hypothyroidism medication.   This case was linked to US-MODERNATX, INC.-MOD-2021-080118, US-MODERNATX, INC.-MOD-2021-080159 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-080118:Husband's case crosslinked US-MODERNATX, INC.-MOD-2021-080159:
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Vaccination site pain, Vomiting
Clinical narrative: migraine headache; Appetite lost; Dizziness; itching; Numb face; tingling; Joint ache; Muscle ache; Vomiting; Fatigue; chills; fever; pain in arm; This spontaneous case was reported by a consumer and describes the occurrence of MIGRAINE (migraine headache), DECREASED APPETITE (Appetite lost), DIZZINESS (Dizziness), PRURITUS (itching) and HYPOAESTHESIA (Numb face) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 025B21A and 006B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Penicillin allergy, Drug allergy (sulfa, gluten, azithromycin,), Food allergy (corn) and Hypothyroidism.   On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 2 dosage form. On 18-Mar-2021, the patient experienced VACCINATION SITE PAIN (pain in arm). On 15-Apr-2021, the patient experienced MIGRAINE (migraine headache), DECREASED APPETITE (Appetite lost), DIZZINESS (Dizziness), PRURITUS (itching), HYPOAESTHESIA (Numb face), PARAESTHESIA (tingling), ARTHRALGIA (Joint ache), MYALGIA (Muscle ache), VOMITING (Vomiting), FATIGUE (Fatigue), CHILLS (chills) and PYREXIA (fever). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) at an unspecified dose and frequency. At the time of the report, MIGRAINE (migraine headache), DECREASED APPETITE (Appetite lost), DIZZINESS (Dizziness), VACCINATION SITE PAIN (pain in arm), ARTHRALGIA (Joint ache), MYALGIA (Muscle ache), FATIGUE (Fatigue), CHILLS (chills) and PYREXIA (fever) had not resolved and PRURITUS (itching), HYPOAESTHESIA (Numb face), PARAESTHESIA (tingling) and VOMITING (Vomiting) had resolved.            Other concomitant medications include hypothyroidism medication.   This case was linked to US-MODERNATX, INC.-MOD-2021-080118, US-MODERNATX, INC.-MOD-2021-080159 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-080118:Husband's case crosslinked US-MODERNATX, INC.-MOD-2021-080159:
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pain, Vaccination site swelling, Vaccination site warmth
Clinical narrative: Redness in arm; Swelling in arm; Hotness in arm; Soreness in arm; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (Redness in arm), PERIPHERAL SWELLING (Swelling in arm), SKIN WARM (Hotness in arm) and PAIN IN EXTREMITY (Soreness in arm) in a 46-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No Significant Medical History).    On 07-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ERYTHEMA (Redness in arm), PERIPHERAL SWELLING (Swelling in arm), SKIN WARM (Hotness in arm) and PAIN IN EXTREMITY (Soreness in arm). At the time of the report, ERYTHEMA (Redness in arm), PERIPHERAL SWELLING (Swelling in arm), SKIN WARM (Hotness in arm) and PAIN IN EXTREMITY (Soreness in arm) had not resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Vaccination site discolouration, Vaccination site mass
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Hurting arm), PAIN IN EXTREMITY (sore arm), VACCINATION SITE MASS (Lump on her left arm) and VACCINATION SITE DISCOLOURATION (Injection site is blue) in a 47-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 048B21A) for COVID-19 vaccination.     No medical history was provided by reporter. No concomitant medication reported.   On 17-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Apr-2021, the patient experienced PAIN IN EXTREMITY (Hurting arm) and PAIN IN EXTREMITY (sore arm). On 19-Apr-2021, the patient experienced VACCINATION SITE MASS (Lump on her left arm) and VACCINATION SITE DISCOLOURATION (Injection site is blue). At the time of the report, PAIN IN EXTREMITY (Hurting arm), PAIN IN EXTREMITY (sore arm), VACCINATION SITE MASS (Lump on her left arm) and VACCINATION SITE DISCOLOURATION (Injection site is blue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications reported  The patient took TYLENOL to alleviate the symptoms on 18-APR-2021
Sex: F
Vaccine: COVID19
Symptoms: Dysphagia, Feeding disorder, Oropharyngeal pain, Pharyngeal swelling, Vaccination complication
Clinical narrative: side effects; swelling of the throat; sore throat; trouble drinking; can't eat; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 19-Apr-2021 and was forwarded to Moderna on 19-Apr-2021.    This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (side effects), PHARYNGEAL SWELLING (swelling of the throat), OROPHARYNGEAL PAIN (sore throat), DYSPHAGIA (trouble drinking) and FEEDING DISORDER (can't eat) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 10-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (side effects), PHARYNGEAL SWELLING (swelling of the throat), OROPHARYNGEAL PAIN (sore throat), DYSPHAGIA (trouble drinking) and FEEDING DISORDER (can't eat). At the time of the report, VACCINATION COMPLICATION (side effects), PHARYNGEAL SWELLING (swelling of the throat), OROPHARYNGEAL PAIN (sore throat), DYSPHAGIA (trouble drinking) and FEEDING DISORDER (can't eat) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Patient  second shot is 8May2021.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Dysgeusia, Salivary hypersecretion
Clinical narrative: metallic taste; excessive drooling of saliva/extra salivating; This spontaneous case was reported by a consumer and describes the occurrence of DYSGEUSIA (metallic taste) and SALIVARY HYPERSECRETION (excessive drooling of saliva/extra salivating) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 025A21A and 092821A) for COVID-19 vaccination.     The patient's past medical history included Hives. Previously administered products included for Herpes zoster: Shingles booster (Fever  100.4 for 4 days.) on 15-Oct-2020. Past adverse reactions to the above products included Fever with Shingles booster. Concomitant products included SERTRALINE HYDROCHLORIDE (ZOLOFT) and TEMAZEPAM (RESTORIL [TEMAZEPAM]) for an unknown indication.   On 22-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 22-Mar-2021, the patient experienced DYSGEUSIA (metallic taste) and SALIVARY HYPERSECRETION (excessive drooling of saliva/extra salivating). On 22-Mar-2021, DYSGEUSIA (metallic taste) had resolved. At the time of the report, SALIVARY HYPERSECRETION (excessive drooling of saliva/extra salivating) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment medications were reported Action taken with mRNA-1273 in response to the events were Not Applicable    This case was linked to MOD-2021-162702 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 24-May-2021: Follow-up was received on 24-MAY-2021 which updated patient demographics, historical conditions, facility name, concomitant medications and re-challenge date.
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Foot fracture
Clinical narrative: This spontaneous case reported by a consumer, describes the occurrence of foot fracture (fractured his foot) in a 68-year-old male patient who received mRNA-1273 (Moderna COVID-19 vaccine, batch# 044A21A) for COVID-19 immunization. The patient's past medical history included stroke (30 years ago). Concurrent medical conditions included speech impairment (NOS). On Mar 27, 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), intramuscular; 1 dosage form. On Apr 5, 2021, patient had a foot fracture (fractured his foot). The patient treated with rehabilitation therapy (2 weeks) for foot fracture. At the time of the report, foot fracture (fractured his foot) outcome: unknown/not provided. The action taken with mRNA-1273 (Moderna COVID-19 vaccine), intramuscular: unknown. No concomitant medication provided.
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Cough, SARS-CoV-2 test
Clinical narrative: Lingering cough; Tested positive for COVID-19; This spontaneous case was reported by a consumer and describes the occurrence of COUGH (Lingering cough) and COVID-19 (Tested positive for COVID-19) in a 60-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040A21A) for COVID-19 vaccination.     Concurrent medical conditions included Blood pressure high.    On 24-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Mar-2021, the patient experienced COVID-19 (Tested positive for COVID-19). On 19-Apr-2021, the patient experienced COUGH (Lingering cough). At the time of the report, COUGH (Lingering cough) and COVID-19 (Tested positive for COVID-19) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 30-Mar-2021, SARS-CoV-2 test: positive (Positive) Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       The patient has not taken any concomitant medication. No treatment information was reported.
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain, Chest pain, Computerised tomogram, Illness, Influenza like illness
Clinical narrative: Abdominal pain; Chest pain; Flu like symptoms; Sick; Spleen became very enlarged; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of SPLENOMEGALY (Spleen became very enlarged), ABDOMINAL PAIN (Abdominal pain), CHEST PAIN (Chest pain), INFLUENZA LIKE ILLNESS (Flu like symptoms) and ILLNESS (Sick) in a 29-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 018b21a) for COVID-19 vaccination.     Concurrent medical conditions included Drug allergy (Amoxicillin ), Drug allergy (Zpack.) and Food allergy (allergy to other products.). Concomitant products included LORAZEPAM (ATIVAN) for an unknown indication.    On 05-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Apr-2021, the patient experienced SPLENOMEGALY (Spleen became very enlarged). On an unknown date, the patient experienced ABDOMINAL PAIN (Abdominal pain), CHEST PAIN (Chest pain), INFLUENZA LIKE ILLNESS (Flu like symptoms) and ILLNESS (Sick). At the time of the report, SPLENOMEGALY (Spleen became very enlarged) had not resolved and ABDOMINAL PAIN (Abdominal pain), CHEST PAIN (Chest pain), INFLUENZA LIKE ILLNESS (Flu like symptoms) and ILLNESS (Sick) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Computerised tomogram: enlarged spleen (abnormal) Enlarged spleen.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. Treatment is not provided   Most recent FOLLOW-UP information incorporated above includes: On 20-May-2021: Medical history, Lab data and new events
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Splenomegaly
Clinical narrative: Abdominal pain; Chest pain; Flu like symptoms; Sick; Spleen became very enlarged; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of SPLENOMEGALY (Spleen became very enlarged), ABDOMINAL PAIN (Abdominal pain), CHEST PAIN (Chest pain), INFLUENZA LIKE ILLNESS (Flu like symptoms) and ILLNESS (Sick) in a 29-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 018b21a) for COVID-19 vaccination.     Concurrent medical conditions included Drug allergy (Amoxicillin ), Drug allergy (Zpack.) and Food allergy (allergy to other products.). Concomitant products included LORAZEPAM (ATIVAN) for an unknown indication.    On 05-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Apr-2021, the patient experienced SPLENOMEGALY (Spleen became very enlarged). On an unknown date, the patient experienced ABDOMINAL PAIN (Abdominal pain), CHEST PAIN (Chest pain), INFLUENZA LIKE ILLNESS (Flu like symptoms) and ILLNESS (Sick). At the time of the report, SPLENOMEGALY (Spleen became very enlarged) had not resolved and ABDOMINAL PAIN (Abdominal pain), CHEST PAIN (Chest pain), INFLUENZA LIKE ILLNESS (Flu like symptoms) and ILLNESS (Sick) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Computerised tomogram: enlarged spleen (abnormal) Enlarged spleen.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. Treatment is not provided   Most recent FOLLOW-UP information incorporated above includes: On 20-May-2021: Medical history, Lab data and new events
Age: 84.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Insomnia, Myalgia, Pain, Pain in extremity
Clinical narrative: Everything hurts; Ankles were in pain; Knees were in pain; Hips were in pain; Shoulders were in pain; Arms were in pain; Has pain ever since; Couldn't sleep; This spontaneous case was reported by a consumer and describes the occurrence of INSOMNIA (Couldn't sleep), PAIN IN EXTREMITY (Arms were in pain), PAIN (Has pain ever since), MYALGIA (Everything hurts) and ARTHRALGIA (Ankles were in pain) in an 84-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001R21$) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Hypertension and Hyperlipidemia.   On 31-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 ml. On 10-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 10-Apr-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced PAIN (Has pain ever since). On 11-Apr-2021, the patient experienced PAIN IN EXTREMITY (Arms were in pain), MYALGIA (Everything hurts), ARTHRALGIA (Ankles were in pain), ARTHRALGIA (Knees were in pain), ARTHRALGIA (Hips were in pain) and ARTHRALGIA (Shoulders were in pain). In April 2021, the patient experienced INSOMNIA (Couldn't sleep). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 1 dosage form. At the time of the report, INSOMNIA (Couldn't sleep), PAIN IN EXTREMITY (Arms were in pain), PAIN (Has pain ever since), MYALGIA (Everything hurts), ARTHRALGIA (Ankles were in pain), ARTHRALGIA (Knees were in pain), ARTHRALGIA (Hips were in pain) and ARTHRALGIA (Shoulders were in pain) outcome was unknown.            Concomitant product included blood pressure medications and cholesterol medications. Action taken with mRNA-1273 in response to the events was not applicable. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Most recent FOLLOW-UP information incorporated above includes: On 26-Apr-2021: Updated vaccine information, Concomitant medications were added, and  Event added.
Sex: M
Vaccine: COVID19
Symptoms: Back pain, Myalgia
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of BACK PAIN (back pain) and MYALGIA (muscle pain in middle of back near spine) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 20-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 18-Apr-2021, the patient experienced BACK PAIN (back pain) and MYALGIA (muscle pain in middle of back near spine). At the time of the report, BACK PAIN (back pain) and MYALGIA (muscle pain in middle of back near spine) outcome was unknown.            No concomitant and treatment medications were reported.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Blood test, Burning sensation, Dermatitis contact, Erythema, Pruritus
Clinical narrative: burning sensation; rash spreading on left low in calf muscle area then right lower left calf; itching; redness; This spontaneous case was reported by a consumer and describes the occurrence of BURNING SENSATION (burning sensation), DERMATITIS CONTACT (rash spreading on left low in calf muscle area then right lower left calf), PRURITUS (itching) and ERYTHEMA (redness) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036A21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products included SALBUTAMOL (PROVENTIL [SALBUTAMOL]) for an unknown indication.    On 25-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Mar-2021, the patient experienced BURNING SENSATION (burning sensation), DERMATITIS CONTACT (rash spreading on left low in calf muscle area then right lower left calf), PRURITUS (itching) and ERYTHEMA (redness). The patient was treated with TRIAMCINOLONE at a dose of 1 dosage form and CLOBETASOL ongoing since an unknown date at a dose of 1 dosage form. At the time of the report, BURNING SENSATION (burning sensation), DERMATITIS CONTACT (rash spreading on left low in calf muscle area then right lower left calf), PRURITUS (itching) and ERYTHEMA (redness) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood test: negative Negative.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Benthemethasone was also used for treatment
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Pyrexia
Clinical narrative: Began having chills; Low grade fever of 100.2F; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (Began having chills) and PYREXIA (Low grade fever of 100.2F) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Spinal operation (Spinal surgery 5 weeks ago).    On 10-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Apr-2021, the patient experienced CHILLS (Began having chills) and PYREXIA (Low grade fever of 100.2F). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, CHILLS (Began having chills) and PYREXIA (Low grade fever of 100.2F) had not resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication information not provided.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Ageusia, Vaccination site pain
Clinical narrative: Loss of taste; Little arm soreness at injection arm; This spontaneous case was reported by a consumer and describes the occurrence of AGEUSIA (Loss of taste) and VACCINATION SITE PAIN (Little arm soreness at injection arm) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040B21A) for COVID-19 vaccination.     Concomitant products included METFORMIN HYDROCHLORIDE (GLUCOPHAGE FORTE), GLIPIZIDE, NIFEDIPINE, ATENOLOL, MAGNESIUM, POTASSIUM and MINERALS NOS, VITAMINS NOS (MULTIVITAMIN AND MINERAL SUPPLEMENT) for an unknown indication.   On 20-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 18-Apr-2021, the patient experienced AGEUSIA (Loss of taste) and VACCINATION SITE PAIN (Little arm soreness at injection arm). At the time of the report, AGEUSIA (Loss of taste) and VACCINATION SITE PAIN (Little arm soreness at injection arm) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications were not reported.  No treatment details were provided    This case was linked to MOD-2021-080163 (Patient Link).
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Dysgeusia, Hypoaesthesia oral, Thirst
Clinical narrative: Got the vaccine at 3:30pm after that got very thirsty and at 11:00pm started to have a very strong metallic flavor, even felt the tip of the tongue a little numb.
Age: 22.0
Sex: F
Vaccine: COVID19
Symptoms: Paraesthesia
Clinical narrative: Tingling arms legs now stomach  H/o neuropathy from chemotherapy previously resolved  Never had stomach tingling
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Hypotension, Myalgia, Syncope
Clinical narrative: Very low BP. Syncope. Muscle pain.
Age: 17.0
Sex: F
Vaccine: COVID19
Symptoms: Fall, Nausea, Unresponsive to stimuli
Clinical narrative: A few minutes after the vaccination, patient started feeling very nauseous.  After 10 minutes, patient was falling off the chair that she was sitting in.  Patient was positioned on the floor because she was not very responsive.  She was breathing and she had a pulse.  911 was called.
Age: 34.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Confusional state, Headache, Malaise, Pyrexia
Clinical narrative: About 12 hours after I received the shot when I was about to go to bed I started shivering severely, after about 10 minutes of constant shivering I got a fever that reached 101.9. The shivering continued for a total of 35-45 minutes than subsided to just the fever and a headache. My mother said I was talking out of my head and didn?t make any sense. But I finally fell asleep and here it is 4 days layers those symptoms are gone but I still feel malaise.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Lymphadenopathy, Myalgia, Pain in extremity, Peripheral swelling
Clinical narrative: swollen lymph nodes under right arm, right chest wall, right neck, fever, pain in muscle, pain in hands, swelling in right leg, swelling in hands, headache, feet hurt under bottom,
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: swollen lymph nodes under right arm, right chest wall, right neck, fever, pain in muscle, pain in hands, swelling in right leg, swelling in hands, headache, feet hurt under bottom,
Age: 24.0
Sex: F
Vaccine: COVID19
Symptoms: Chest discomfort, Chest pain, Chills, Dizziness, Fatigue
Clinical narrative: Systemic: Chest Tightness / Heaviness / Pain-Mild, Systemic: Chills-Mild, Systemic: Dizziness / Lightheadness-Mild, Systemic: Exhaustion / Lethargy-Mild, Systemic: Nausea-Mild
Age: 24.0
Sex: F
Vaccine: COVID19
Symptoms: Lethargy, Nausea
Clinical narrative: Systemic: Chest Tightness / Heaviness / Pain-Mild, Systemic: Chills-Mild, Systemic: Dizziness / Lightheadness-Mild, Systemic: Exhaustion / Lethargy-Mild, Systemic: Nausea-Mild
Age: 22.0
Sex: M
Vaccine: COVID19
Symptoms: Cough, Malaise
Clinical narrative: Feeling sick for now 4 days, almost 96 hours after I got my vaccine. Can?t find one section on CDC where it says you?ll be having a bad cough for days; just says fever and it will last 1-2 days. You guys really don?t know shit do you?
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Cough, Pruritus, Rash, Urticaria
Clinical narrative: Systemic: Allergic: Itch (specify: facial area, extremeties)-Medium, Systemic: Allergic: Itch Generalized-Medium, Systemic: Allergic: Rash (specify: facial area, extremeties)-Medium, Systemic: Allergic: Rash Generalized-Medium, Additional Details: Patient came in to pharmacy on 08-21-21 stating hives and cough started post moderna vaccination. Patient wanted report to be filed
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Chapped lips, Cheilitis, Lip swelling
Clinical narrative: A few days after the first vaccine my lips became very large, swollen, and I developed a very bad rash-like chapping around the outer edge of my lips.  My lips were very sore and peeled and peeled. This lasted at least a month, and just started to go away when I received the second vaccine on 4/7/2021. The rash-like chapping has continued to a lesser degree until now, off and on for months after receiving the vaccine. My lips still also get slightly swollen as well. Not quite as bad as right after the first shot, but slightly swollen. The chapping peels off, and then the cycle starts all over again.  My lips are swollen today, and beginning to chap again.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Limb discomfort, Myalgia, Somnolence, Urticaria
Clinical narrative: FELT GROGGY; TIRED AFTER THE VACCINE;TIREDNESS; PREVALENT RED MARK ON ARM; Arm has been pulsing, arm is still pulsing sporadically; Sore arm; FELT ITCHY AT INJECTION SITE;ITCHNESS; INTERNAL HIVES; This spontaneous case was reported by a consumer and describes the occurrence of SOMNOLENCE (FELT GROGGY), VACCINATION COMPLICATION (TIRED AFTER THE VACCINE;TIREDNESS), URTICARIA (INTERNAL HIVES), LIMB DISCOMFORT (Arm has been pulsing, arm is still pulsing sporadically) and MYALGIA (Sore arm) in a 43-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 046A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 01-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced SOMNOLENCE (FELT GROGGY), VACCINATION COMPLICATION (TIRED AFTER THE VACCINE;TIREDNESS), URTICARIA (INTERNAL HIVES), LIMB DISCOMFORT (Arm has been pulsing, arm is still pulsing sporadically), MYALGIA (Sore arm), VACCINATION SITE PRURITUS (FELT ITCHY AT INJECTION SITE;ITCHNESS) and ERYTHEMA (PREVALENT RED MARK ON ARM). At the time of the report, SOMNOLENCE (FELT GROGGY), VACCINATION COMPLICATION (TIRED AFTER THE VACCINE;TIREDNESS), LIMB DISCOMFORT (Arm has been pulsing, arm is still pulsing sporadically), MYALGIA (Sore arm) and ERYTHEMA (PREVALENT RED MARK ON ARM) outcome was unknown and URTICARIA (INTERNAL HIVES) and VACCINATION SITE PRURITUS (FELT ITCHY AT INJECTION SITE;ITCHNESS) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medications includes Thyroid Medication.  No treatment information were reported.   Most recent FOLLOW-UP information incorporated above includes: On 21-Apr-2021: Follow up received on 21-Apr-2021: added reporter information, update patients tab, updated products tab, update events and added events prevalent red mark on the arm as  and arm has been pulsing; arm is still pulsing sporadically.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination complication, Vaccination site pruritus
Clinical narrative: FELT GROGGY; TIRED AFTER THE VACCINE;TIREDNESS; PREVALENT RED MARK ON ARM; Arm has been pulsing, arm is still pulsing sporadically; Sore arm; FELT ITCHY AT INJECTION SITE;ITCHNESS; INTERNAL HIVES; This spontaneous case was reported by a consumer and describes the occurrence of SOMNOLENCE (FELT GROGGY), VACCINATION COMPLICATION (TIRED AFTER THE VACCINE;TIREDNESS), URTICARIA (INTERNAL HIVES), LIMB DISCOMFORT (Arm has been pulsing, arm is still pulsing sporadically) and MYALGIA (Sore arm) in a 43-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 046A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 01-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced SOMNOLENCE (FELT GROGGY), VACCINATION COMPLICATION (TIRED AFTER THE VACCINE;TIREDNESS), URTICARIA (INTERNAL HIVES), LIMB DISCOMFORT (Arm has been pulsing, arm is still pulsing sporadically), MYALGIA (Sore arm), VACCINATION SITE PRURITUS (FELT ITCHY AT INJECTION SITE;ITCHNESS) and ERYTHEMA (PREVALENT RED MARK ON ARM). At the time of the report, SOMNOLENCE (FELT GROGGY), VACCINATION COMPLICATION (TIRED AFTER THE VACCINE;TIREDNESS), LIMB DISCOMFORT (Arm has been pulsing, arm is still pulsing sporadically), MYALGIA (Sore arm) and ERYTHEMA (PREVALENT RED MARK ON ARM) outcome was unknown and URTICARIA (INTERNAL HIVES) and VACCINATION SITE PRURITUS (FELT ITCHY AT INJECTION SITE;ITCHNESS) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medications includes Thyroid Medication.  No treatment information were reported.   Most recent FOLLOW-UP information incorporated above includes: On 21-Apr-2021: Follow up received on 21-Apr-2021: added reporter information, update patients tab, updated products tab, update events and added events prevalent red mark on the arm as  and arm has been pulsing; arm is still pulsing sporadically.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema, Injection site swelling, Lymphadenopathy
Clinical narrative: Site: Redness at Injection Site-Mild, Site: Swelling at Injection Site-Mild, Systemic: Lymph Node Swelling-Mild
Age: 59.0
Sex: M
Vaccine: COVID19
Symptoms: Vertigo
Clinical narrative: Vertigo; This spontaneous case was reported by a consumer and describes the occurrence of VERTIGO (Vertigo) in a 59-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 020B21A and 025A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 2 dosage form. On 18-Apr-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced VERTIGO (Vertigo). At the time of the report, VERTIGO (Vertigo) outcome was unknown. Not Provided          This case was linked to US-MODERNATX, INC.-MOD-2021-083759 (E2B Linked Report). This case was linked to MOD-2021-080242 (Patient Link).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-083759:cross linked case
Age: 17.0
Sex: M
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: Vaccine administered to 17 year old patient; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Vaccine administered to 17 year old patient) in a 17-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Vaccine administered to 17 year old patient). At the time of the report, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Vaccine administered to 17 year old patient) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant and treatment medication were not provided.
Sex: F
Vaccine: COVID19
Symptoms: Abdominal discomfort, Chills, Feeling abnormal, Myalgia, Nausea
Clinical narrative: Slept most of the next day; Stomach discomfort; Feeling of brain fogginess; Body ache; Chills; Nausea; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of SOMNOLENCE (Slept most of the next day), ABDOMINAL DISCOMFORT (Stomach discomfort), FEELING ABNORMAL (Feeling of brain fogginess), MYALGIA (Body ache) and CHILLS (Chills) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 031B21A and 044A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 09-Apr-2021, the patient experienced ABDOMINAL DISCOMFORT (Stomach discomfort), FEELING ABNORMAL (Feeling of brain fogginess), MYALGIA (Body ache), CHILLS (Chills) and NAUSEA (Nausea). On 10-Apr-2021, the patient experienced SOMNOLENCE (Slept most of the next day). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, SOMNOLENCE (Slept most of the next day), ABDOMINAL DISCOMFORT (Stomach discomfort), FEELING ABNORMAL (Feeling of brain fogginess), MYALGIA (Body ache), CHILLS (Chills) and NAUSEA (Nausea) had resolved.            Concomitant products included multivitamins. Action taken with mRNA-1273 in response to the events were not applicable.   This case was linked to MOD21-077255 (E2B Linked Report).; Sender's Comments:  MOD21-077255:
Sex: F
Vaccine: COVID19
Symptoms: Somnolence
Clinical narrative: Slept most of the next day; Stomach discomfort; Feeling of brain fogginess; Body ache; Chills; Nausea; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of SOMNOLENCE (Slept most of the next day), ABDOMINAL DISCOMFORT (Stomach discomfort), FEELING ABNORMAL (Feeling of brain fogginess), MYALGIA (Body ache) and CHILLS (Chills) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 031B21A and 044A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 09-Apr-2021, the patient experienced ABDOMINAL DISCOMFORT (Stomach discomfort), FEELING ABNORMAL (Feeling of brain fogginess), MYALGIA (Body ache), CHILLS (Chills) and NAUSEA (Nausea). On 10-Apr-2021, the patient experienced SOMNOLENCE (Slept most of the next day). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, SOMNOLENCE (Slept most of the next day), ABDOMINAL DISCOMFORT (Stomach discomfort), FEELING ABNORMAL (Feeling of brain fogginess), MYALGIA (Body ache), CHILLS (Chills) and NAUSEA (Nausea) had resolved.            Concomitant products included multivitamins. Action taken with mRNA-1273 in response to the events were not applicable.   This case was linked to MOD21-077255 (E2B Linked Report).; Sender's Comments:  MOD21-077255:
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Vaccination site pain
Clinical narrative: Pain in arm; Injection site pain; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Pain in arm) and VACCINATION SITE PAIN (Injection site pain) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037B21A) for COVID-19 vaccination.     No medical history provided by the reporter.  Concomitant products included FLUOXETINE HYDROCHLORIDE (PROZAC) for an unknown indication.    On 18-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Pain in arm) and VACCINATION SITE PAIN (Injection site pain). At the time of the report, PAIN IN EXTREMITY (Pain in arm) and VACCINATION SITE PAIN (Injection site pain) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient didn't take any treatment.   Reporter did not allow further contact
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Fatigue, Hyperhidrosis, Myalgia, Pyrexia
Clinical narrative: Fatigue; Chills; fever 101 degrees, I can get it down to about 99 degrees, but then it goes back up, ever since; Aches on the inside; sweats at night; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (Fatigue), CHILLS (Chills), PYREXIA (fever 101 degrees, I can get it down to about 99 degrees, but then it goes back up, ever since), MYALGIA (Aches on the inside) and HYPERHIDROSIS (sweats at night) in a 63-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032B21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products included AMLODIPINE BESYLATE and ATORVASTATIN for an unknown indication.    On 13-Apr-2021 at 9:40 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Apr-2021, the patient experienced FATIGUE (Fatigue), CHILLS (Chills), PYREXIA (fever 101 degrees, I can get it down to about 99 degrees, but then it goes back up, ever since), MYALGIA (Aches on the inside) and HYPERHIDROSIS (sweats at night). The patient was treated with PARACETAMOL (TYLENOL) ongoing since an unknown date at a dose of UNK, q4h and IBUPROFEN ongoing since an unknown date at a dose of UNK, q4h. At the time of the report, FATIGUE (Fatigue), CHILLS (Chills), PYREXIA (fever 101 degrees, I can get it down to about 99 degrees, but then it goes back up, ever since), MYALGIA (Aches on the inside) and HYPERHIDROSIS (sweats at night) was resolving. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Most recent FOLLOW-UP information incorporated above includes: On 19-Apr-2021: Email,Address,County,Concomitant medications,Ethenic group and race were added
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: Depressed mood, Myalgia, Pyrexia
Clinical narrative: achy; feeling down; fever; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (achy), DEPRESSED MOOD (feeling down) and PYREXIA (fever) in a 58-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027A21A) for COVID-19 vaccination.     The patient's past medical history included Nausea, Pain, Fever and .    On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1. On an unknown date, the patient experienced MYALGIA (achy), DEPRESSED MOOD (feeling down) and PYREXIA (fever). At the time of the report, MYALGIA (achy), DEPRESSED MOOD (feeling down) and PYREXIA (fever) outcome was unknown.            This case was linked to US-MODERNATX, INC.-MOD-2021-080215 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-080215:2nd dose events